PateƱo, Cecile P.

HRN: 28-90-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/29/2026
04/29/2026
IVT
1g
Single Dose
Herniated Nucleus Pulposus L4 L5
Checking Initial Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines